scholarly journals GLOBAL TRENDS OF THE STATE HUMAN RESOURCES POLICY IN THE FIELD OF HEALTHCARE

2021 ◽  
Vol 03 (01) ◽  
pp. 106-115
Author(s):  
Malihon Yuliia Malihon Yuliia
Keyword(s):  
Health Care ◽  
Health Care System ◽  
Medical Personnel ◽  
Highly Qualified ◽  
Global Trends ◽  
Cost Of Education ◽  
Qualified Personnel ◽  
The World ◽  
The Cost ◽  
Care System

The article identifies that one of the most pressing problems in the world’s health care system is the shortage of highly qualified personnel. The distribution of medical workers by gender was carried out. The main problems in the staffing of health care in the world are analyzed. The level of provision of the country's health care system with medical personnel has been studied. The peculiarities of receiving medical education and the formation of medical personnel of some countries of the EU and the world are described. The TOP-20 the best medical universities and the cost of education in Germany, as well as the cost of education in leading American medical universities, were analyzed. Keywords: personnel policy, health care system, medical personnel, medical services.

Medical standard as a historical component on the way of clinical audit

2020 ◽  
Vol 26 (4) ◽  
pp. 108-115
Author(s):  
А.B. Zimenkovsky ◽  
◽  
T.G. Gutor ◽  
Keyword(s):  
Health Care ◽  
Great Britain ◽  
Health Care System ◽  
Clinical Audit ◽  
Medical Aid ◽  
The World ◽  
The Usa ◽  
Medical Standard ◽  
Care System

Aim - the search, analysis and systematization of historical facts concerning the formation and evo-lution of the world medical standartization; severance of its certain long-standing models for the optimization of settling and introduction of the existing, and future analogs, particularly, in the clinical audit format. Material and Methods. In order to study the medical standard as a historical component the fol-lowing methods were used: bibliographic, historical, analytical and methods of systematization and comparison. Results and Discussion. As a result of the conducted research the main historical events in the world development of the medical standartization starting from 1500 up till nowadays were col-lected. In order to study the evolution of the medical standartization, the analysis of the normative documents that have regulated the process of standartization, especially the Doctor's statute(s) in Russia, Minimal standard of the medical equipment and works of the American college of surgeons, was carried out. The scientific works that initiated the introduction of the clinical audit in the Health Care system in Ukraine, Turkey, the USA and Great Britain were throroughly analyzed. Conclusions. The improvement of quality as to rendering the medical aid is a job priority in the health care systems in many countries. For that reason, the search for its optimization was and is still retrieved for many centuries. The territorial formation of medical standartization is associated with England, Russia and the USA, but the occurrence of clinical audit is connected with Ukraine, Turkey, the USA and Great Britain. The foundations of the medical standardization was lauched in 1500 year, while the clinical audit - in 1854 year. The medical standartization is a reflection of the history of development of the organization of health care system, that's why the expertness (knowl-edge) of historical stages concerning the setting and the introduction of medical standartization may give a new impulse in its improvement and development under present-day conditions of reforma-tion in the medical sphere in Ukraine. The earlier beginning of implementation of the medical stan-dartization in the health care system in different countries makes it possible to actualize its introduc-tion into the clinical audit format, that, in its turn, allows to improve the quality of rendering the medical aid. Key words: medical standartization, clinical audit, quality of medical aid

scholarly journals Reoperation costs in attempted breast-conserving surgery: a decision analysis

2016 ◽  
Vol 23 (5) ◽  
pp. 314 ◽  
Author(s):  
R. Pataky ◽  
C.R. Baliski
Keyword(s):  
Health Care ◽  
Breast Reconstruction ◽  
Patient Care ◽  
Health Care System ◽  
Early Stage ◽  
Treatment Options ◽  
Breast Conserving Surgery ◽  
Reoperation Rate ◽  
The Cost ◽  
Care System

Background Breast-conserving surgery (bcs) is the preferred surgical approach for most patients with early-stage breast cancer. Frequently, concerns arise about the pathologic margin status, resulting in an average reoperation rate of 23% in Canada. No consensus has been reached about the ideal reoperation rate, although 10% has been suggested as a target. Upon undergoing reoperation, many patients choose mastectomy and breast reconstruction, which add to the morbidity and cost of patient care. We attempted to identify the cost of reoperation after bcs, and the effect that a reduction in the reoperation rate could have on the B.C. health care system.Methods A decision tree was constructed to estimate the average cost per patient undergoing initial bcs with two reoperation frequency scenarios: 23% and 10%. The model included the direct medical costs from the perspective of the B.C. health care system for the most common surgical treatment options, including breast reconstruction and postoperative radiation therapy.Results Costs ranged from a low of $8,225 per patient with definitive bcs [95% confidence interval (ci): $8,061 to $8,383] to a high of $26,026 for reoperation with mastectomy and delayed reconstruction (95% ci: $23,991 to $28,122). If the reoperation rate could be reduced to 10%, the average saving would be $1,055 per patient undergoing attempted bcs (95% ci: $959 to $1,156). If the lower rate were to be achieved in British Columbia, it would translate into a savings of $1.9 million annually.Summary The implementation of initiatives to reduce reoperation after bcs could result in significant savings to the health care system, while potentially improving the quality of patient care.

scholarly journals Access barriers to visual health

2018 ◽  
Vol 16 (1) ◽  
pp. 95-109 ◽  
Author(s):  
María Alejandra Rodríguez-Echeverría ◽  
Angélica María Páez-Castro
Keyword(s):  
Health Care ◽  
Literature Review ◽  
Health Care System ◽  
World Health ◽  
Local Health Authority ◽  
Barriers To Access ◽  
The World ◽  
Health Organization ◽  
Visual Health ◽  
Care System

A number of factors and conditions hinder and restrict access to the health care system and its different services; these barriers to access put at risk the health of people by affecting adequate processes. Objective: To carry out a literature review on barriers to access to the health care system and visual health services in Colombia and around the world. Methodology: A literature review was carried out based on a search of the Medline, ScienceDirect, and Pubmed databases, as well as indexed public health journals and the websites of the Local Health Authority, the World Health Organization, the Pan American Health Organization, the UNESCO, and the Brien Holden Vision Institute. Results: The main barriers related to demand, both in general services and in visual health, are the lack of perception on the need for service and lack of economic resources; at the offer level, the existing policies constitute a real obstacle. Conclusions: Awareness-raising in the population, together with the implementation of health policies that grant equal access to health care services, are fundamental to prevent people from being affected, to a large extent, by barriers related to demand or offer, regardless of their location or level of income.

scholarly journals The Cuban Healthcare System: An Insight

2021 ◽  
pp. 63-69
Author(s):  
Nisha Zahid ◽  
Farah Ahmed ◽  
Noor Israr ◽  
Akhtar Ali ◽  
Sidra Farooq ◽  
...  
Keyword(s):  
Health Care ◽  
Healthcare System ◽  
Health Care System ◽  
Swot Analysis ◽  
Healthcare Services ◽  
Developed Countries ◽  
Primary Health Care System ◽  
Public Health Policies ◽  
The World ◽  
Care System

All the countries in the world are struggling to improve their healthcare systems regardless of being rich or poor. Talking about Cuba, it represents an example of well-developed healthcare system and policies which is comparable to developed countries of the world. The success of Cuban healthcare system largely depends upon its strong primary health care system, proper immunization, robust public health policies, treating all the population classes equally providing them with free healthcare services. The control of infection spread and non-communicable diseases also contributes to the success of Cuban Healthcare system. We have discussed the Cuban health care system from start till the current situation and also, we performed SWOT analysis to bring the clearer depiction of the Cuban Healthcare System as it highlights the key internal and external issues which are further discussed in detail.

Validation of an MRI-Based Method to Measure Tibiofemoral Joint Cartilage Contact Area

2011 ◽  
Author(s):  
Jerome Allen ◽  
Venkata Gade ◽  
Peter J. Barrance
Keyword(s):  
Health Care ◽  
Health Care System ◽  
Contact Area ◽  
Functional Activity ◽  
Physical Disability ◽  
Joint Disease ◽  
Joint Cartilage ◽  
Tibiofemoral Joint ◽  
The World ◽  
Care System

Osteoarthritis is a progressive and debilitating joint disease that is the leading cause of physical disability in industrial nations around the world [1]. It not only negatively affects the comfort and functional activity of individuals, but as a result also taxes the health care system of these countries.

A Specialized Home Care Team Does Make a Difference

1992 ◽  
Vol 5 (3) ◽  
pp. 38-41
Author(s):  
Dorothy Larson ◽  
Ralph Odegard ◽  
N.E. Brown
Keyword(s):  
Health Care ◽  
Home Care ◽  
Health Care System ◽  
Care Program ◽  
Care Team ◽  
Research Facility ◽  
Teaching And Research ◽  
The Cost ◽  
Care System ◽  
At Home

Results of a study done in a large teaching and research facility in Alberta reveal that a specialized home care team can substantially lower the cost of caring for people who are ventilator dependent. With the assistance of a pulmonary physician, the Respiratory Home Care program has shown excellent results. Patients report that they “feel as safe at home as in the hospital”, and the savings to the health care system are estimated to be about $2,000,000 per year.

The cost burden of trastuzumab and bevacizumab monoclonal antibody therapy in solid tumors: Can we afford it?

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 6044-6044 ◽  
Author(s):  
A. Drucker ◽  
K. Virik ◽  
C. Skedgel ◽  
D. Rayson ◽  
M. Sellon ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care System ◽  
Drug Costs ◽  
Cost Burden ◽  
Care Providers ◽  
Treatment Standard ◽  
Pharmacy Data ◽  
The Cost ◽  
The Impact ◽  
Care System

6044 Background: Monoclonal antibodies (MAb), such as trastuzumab (TZ) and bevacizumab (BZ), have become an important yet expensive component of cancer treatment. The potential cost impact on health care budgets needs to be assessed in the context of its potential utilization. An estimate of the additional costs incurred by adopting TZ and BZ therapy in breast (BRC), lung (LUC) and colorectal (CRC) cancers was undertaken. Methods: The MAb costs per patient were estimated based on treatment indications, length of treatment, standard doses / schedules and local pharmacy data. Supportive medications, diagnostics and health resources utilization only required for the MAb therapy were also examined. This analysis was performed in Canadian dollars ($), and assumes complete drug delivery and uncomplicated cycles. Drug costs were based on average 2005 wholesale prices in Canada. The analysis took a direct payer perspective. We subsequently estimated the cost of MAb therapy per patient relative to the total costs of conventional cancer management without MAb therapy. Budget impact estimates on Canada’s health care system were then derived according to constructed schema, which accounts for absolute numbers of target patients and systemic therapy utilization. Results: The average costs of TZ per treated patient were $47,278 and $26,648 for adjuvant and metastatic BRC, respectively. For BZ, these were $47,250 and $38,500 for metastatic LUC and CRC, respectively. Other costs associated with MAb therapy were in the range of 3–6%. The predicted TZ drug costs in metastatic breast cancer were within 10% of the actual costs derived from pharmacy data. The potential life-time absolute costs to Canada’s health care system were approximately $118 million for TZ, and $262 million for BZ. This corresponds to an average of approximately 21% increase in the health care expenditure for BRC, LUC, and CRC. Conclusions: MAb therapy, such as TZ and BZ, may add a significant cost burden to Canada’s publicly funded health care system. The developed schema in this analysis may be of potential use to health care providers and policy makers in assessing the impact of MAb therapy on health care budgets. No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document